with Rb loss of function in tumor cell progression.
, p19
ARF overexpression induces The INK4a tumor suppressor locus encodes p16
INK4a
, both G1 and G2 phase arrest in rodent fibroblasts, an inhibitor of cyclin D-dependent kinases, and p19 ARF , whether or not the cells retain INK4a. The unusual orgaan alternative reading frame protein that also blocks nization of the INK4a locus is conserved in humans (Duro cell proliferation. Surprisingly, mice lacking p19
ARF Mao et al., 1995; Stone et al., 1995) and rats expressing functional p16
INK4a develop tumors early in (Swafford et al., 1997) , whereas three related but distinct life. Their embryo fibroblasts (MEFs) do not senesce INK4 genes do not encode analogous ARF proteins. and are transformed by oncogenic Ha-ras alone. ConDisruption of INK4a exon 2 in mice predisposes young version of ARF ؉/؉ or ARF ؉/Ϫ MEF strains to continuanimals to tumor development (Serrano et al., 1996) .
ously proliferating cell lines involves loss of either
Their cultured mouse embryo fibroblasts (MEFs) fail to p19 ARF or p53. p53-mediated checkpoint control is unundergo a senescence crisis and can be transformed perturbed in ARF-null fibroblast strains, whereas p53-by oncogenic ras alleles, which, in the absence of collabnegative cell lines are resistant to p19
ARF

-induced
orating "immortalizing oncogenes," would otherwise ingrowth arrest. Therefore, INK4a encodes growth induce growth arrest (Lloyd et al., 1997; Serrano et al., hibitory proteins that act upstream of the retinoblas-1997). Although it was clear that elimination of exon 2 toma protein and p53. Mutations and deletions tarof INK4a would compromise expression of both p16
INK4a
geting this locus in cancer cells are unlikely to be and p19
ARF
, it has been widely assumed that the observed phenotype stemmed from p16
INK4a disruption functionally equivalent.
alone. We have now selectively disrupted ARF function in mice by deleting exon 1␤ and leaving all p16 INK4a codIntroduction ing sequences intact. Surprisingly, the previously described phenotypic consequences of INK4a disruption The two most frequently inactivated tumor suppressor are reproduced in mice selectively nullizygous for p19 ARF genes in human cancer, irrespective of tumor type, site, alone, indicating that ARF is a bona fide tumor suppresand patient age, are p53 and INK4a (Hall and Peters, sor. Our results further suggest that ARF and p53 regu-1996; Hainaut et al., 1997) . The INK4a locus encodes late senescence of MEFs and that p19 ARF requires wildp16
INK4a
, a specific inhibitor of the cyclin D-dependent type p53 to induce G1 phase arrest. kinases CDK4 and CDK6 (Serrano et al., 1993) that antagonizes their ability to phosphorylate the retinoblasResults toma protein (Rb) and so prevents exit from G1 phase.
Genetic disruption of the p16
INK4a
-cyclin D-dependent
Mice Lacking p19 ARF Express Wild-Type p16 INK4a kinase-Rb pathway is a common event in the life history
We used a conventional targeting vector to ablate ARF of cancer cells, and it is achieved either through inactivaexon 1␤ in mouse embryonic stem cells, replacing it tion of the tumor suppressors (p16
INK4a
, Rb) or by unconwith a neomycin resistance (neo) gene ( Figure 1A ). Exon trolled overexpression of the proto-oncogenes (D-type 1␤ is included within a 7.8 kb AflII fragment that was cyclins, CDK4) (Hunter and Pines, 1994; Weinburg et al., detected with a unique sequence genomic probe, but 1995; Hall and Peters, 1996; Sherr et al., 1996) . Concuran AflII site inserted into the neo cassette reduced the rent inactivation of p53 function inhibits such cells from size of the hybridizing fragment to 6 kb. Germline transarresting in G1 phase following DNA damage, decreases mission of the mutant allele from a chimeric founder their genomic stability, and prevents them from undermale and subsequent interbreeding of hemizygous offgoing apoptosis (Gottlieb and Oren, 1996 INK4a expression by sequential precipitation and immunoblotting with antiserum to the mouse p16 C terminus. Top and bottom panels were taken from parallel gels, shown with matched exposures. All precipitations were performed using an excess of titered antibody with equal protein inputs per sample. (B) p16 immunoprecipitates as in (A) were separated on gels and blotted with antiserum directed to CDK4. Because p16 levels are relatively low in ARF ϩ/ϩ cells but increase as cells are passaged, results for coprecipitating CDK4 are shown with strains 3-9 and 3-10 at passage 11. Exposures in (A) and (B) are matched. mice confirmed that they lacked mutations. ARF . RTmutants described to date, including those that are tem-PCR analysis showed that ARF ␤ transcripts amplified perature-sensitive, block the protein's ability to bind to from primers based on 5Ј exon 1␤ and 3Ј exon-2 se-CDK4 (Koh et al., 1995; Lukas et al., 1995;  Ranade et quences were expressed in testes and livers of ARF ϩ/ϩ Reymond and Brent, 1995; Wick et al., 1995;  animals ( Figure 1C , lanes 2 and 3), but they were absent Yang et al., 1995; Figure 3A) . In contrast, cultures from ARF Ϫ/Ϫ embryos accumulated many more cells. At passage 5, they proliferated at significantly faster rates than their ARF ϩ/ϩ counterparts and grew to 3-fold higher densities at confluence ( Figure 3B ; note log scale on ordinate Figure 3B ), and they proliferated continuously thereafter never undergoing a detectable senescence crisis ( Figure 3A) . Therefore, ARF Ϫ/Ϫ cells have an increased proliferative capacity, grow faster, and are somewhat less responsive to inhibition by cell-to-cell contact than their wild-type counterparts.
Another property of INK4a nullizygous MEFs is their capacity to be directly transformed by oncogenic ras alleles without a further requirement for collaborating "immortalizing genes," such as E1a or myc (Serrano et al., 1996; Weinberg, 1997 INK4a that coprecipitated with CDK4 ( Figure  3Cc ). Early passage ARF Ϫ/Ϫ cultures yielded no cells tated with an antibody (PAb246) that does not react with mutant forms (Yewdell et al., 1986) . After emergence from crisis, however, MEFs from three strains had sus-(Gannon et al., 1990) (lanes 5-7). Like MEL cells, which tained p53 mutations, as determined by selective precontain a disrupted p53 gene, and others lacking funccipitation of p53 by an antibody (PAb240) that recognizes mutant p53s but not the native p53 conformation tional p53 (Quelle et al., 1995b) , these three MEF lines Figure 3A ), preferentially yielding ARF Ϫ/Ϫ variants. Wildtype and mutant ARF alleles were detected with an exon 1␤ probe in MEFs from three such clones at passage 1, but only mutant ARF was detected at passage 20 when proliferating variants had emerged ( Figure 4B ). ARF Ϫ/Ϫ variants arising from ARF ϩ/Ϫ MEF strains (lanes 2, 4, and 6), MEF lines from ARF-null mice (e.g., lanes 9 and 10), or cell lines arising from wild-type MEFs that sustained biallelic ARF deletions (lanes 8 and 11) synthesized only wild-type p53 (Figures 4B and 5, and data not shown). Conversely, cell lines that retained wildtype ARF alleles synthesized mutant p53 (e.g., Figure  4A , lanes 5-7; Figure 4B , lanes 7 and 12). Cell lines containing mutant p53 and retaining ARF rapidly became polyploid (cf. Harvey et al., 1993; Fukusawa et al., 1996) , but all ARF
ϩ lines remained pseudodiploid through additional passages (cf. Zindy et al., 1997 ; also clones 3-2 and 3-3 through passage 27). In short, functional loss of p53 or p19 ARF appeared to be mutually exclusive events as cells overcame a senescence block, with p53 predisposing to more rapid ploidy changes.
Although wild-type MEFs that sustained biallelic deletions of ARF lacked flanking INK4a and INK4b genes ( Figure 4B , lanes 8 and 11), those containing a single neo-disrupted ARF allele gave rise to ARF Ϫ/Ϫ variants that retained INK4a ( Figure 4B , lanes 1-6, exon 1␣ probe) and expressed both p16
INK4a and p15 INK4b ( Figure 4C ). These results strongly suggest that selection for ARF loss results in codeletion of INK4a and INK4b and not vice versa. BrdU. Cells were stained for DNA content (propidium iodide) and replicative DNA synthesis (BrdU) 24 hr after release from the G0 block, and the S phase fractions were determined by flow cytometry. Although p53-negative synthesized abundant p19 ARF and even higher levels of p16
ARF-Induced Arrest Depends on p53
INK4a than those seen in early passage strains (lanes MEFs are not inhibited from entering S phase after irradiation (Kastan et al., 1991; Kuerbitz et al., 1992; Deng et 5-7 Figure 5C ). The latter cells expressed elevated levels of endogenous p19
ARF (e.g., Figure 4A , lanes 5-7) that closely approximated those achieved in vector-infected p53 ϩ /ARF-null clones (Quelle et al., 1995b) . In summary, 7 of 7 tested cell lines lacking p53 function lost responsiveness to p19 ARF , while 4 of 4 p53 ϩ /ARF-null lines were sensitive.
Although basal p53 levels were similar in ARF Ϫ/Ϫ and ARF ϩ/ϩ cells ( Figure 5A ), ARF-null MEFs reproducibly expressed lower levels of p21
Cip1 (e.g., Figure 5B , 0 hr). In cells infected with retroviral vectors encoding p19 ARF , p53 and p21
Cip1 were induced in clones expressing wildtype p53, regardless of their ARF genotype ( Figure 5D ). In contrast, cells lacking p53 [clone 10(1)] or containing mutant p53 (5-9) exhibited no p19
ARF -dependent induction of p21
Cip1 ; these observations were reproduced in lines 10(3), 5-10, and 6-14. Therefore, ectopic expression of p19
ARF increases p21 Cip1 expression in a p53-dependent manner. the six-month observation period. DMBA treatment pre-(C) MEF strains (clones 3-2, 3-3, 3-9, and 3-10 at passage 9), estabdisposes to development of skin tumors under the con- consistent with historical data (Reiners, et al., 1984;  tion. Results with MEF strains, Balb-3T3 derivatives, and established MEF lines were normalized to values (set to 100%) obtained with Naito and DiGiovanni, 1989) . Four of six mice that were 3-2, 10-1, and 5-9 cells, respectively, infected with the control vector.
␥-irradiated as newborns developed fibrosarcomas or
Standard deviations (data not shown) were less than Ϯ10% of the anaplastic T cell lymphomas. Age refers to date of tumor detection or death of the animal. Where indicated, mice received ionizing radiation (4 Gy) (Kemp et al., 1994) or were treated with DMBA 5-7 days after birth (Serrano et al., 1996) . Nine of 11 DMBA-treated animals, 4 of 6 animals that received sublethal ␥-irradiation, and 6 of 18 untreated mice developed tumors by 5 months of age. Fibrosarcomas arose subcutaneously and were all highly invasive to skeletal muscle and bone. Skin tumors in DMBA-treated animals exhibited variable degrees of anaplasia, with lower grade papillomatous growths sometimes arising at multiple independent sites, and with higher grade carcinomas presenting as either locally invasive or frankly metastatic variants. Lymphomas were anaplastic large-cell type with T cell markers. Detection of p16 INK4a transcripts (PCR) or protein (immunoblotting) in primary tumor tissues is noted by (ϩ); not done is noted by "N.D."; and RT-PCR products taken for nucleotide sequencing are noted by (*).
wild-type ( Figure 6B) , 1996) . Species with longer life spans likely manifest more stringent controls over cell senescence, and in cultures of human cells, loss of both p53 and ARF, or other collaborating events, may well be required to endow them with an extended proliferative capacity (Rogan et al., 1995; Alcorta et al., 1996; Hara et al., 1996; Noble et al., 1996; Reznikoff et al., 1996; Serrano et al., 1997) . Neither point mutations within ARF exon 1␤ nor promoter hypermethylation have so far been detected in tumors or in tumor-derived cell lines Merlo et al., 1995; Stone et al., 1995; Fitzgerald et al., 1996; Herzog et al., 1996; Kubo et al., 1997; Swafford et al., 1997; Tanaka et al., 1997) . Consequently, ARF inactivation may require biallelic deletions, as opposed to p53, whose dominant-negative mutants subvert the function of the wild-type tetrameric product. During passage in culture, ARF ϩ/Ϫ MEFs sustained deletions of their remaining ARF allele while retaining wildtype p53, and such strains became established as cell lines 4-6 passages earlier than ARF ϩ/ϩ cells. In normal MEFs containing two wild-type ARF alleles, p53 mutation is readily detected (Harvey and Levine, 1991) , but in cells hemizygous for ARF, loss of the remaining wildtype ARF allele is at least as frequent an occurrence.
MEF cell lines lacking ARF, whether directly derived from nullizygous animals or from wild-type cells that had deleted both copies of the gene during the process of establishment, promptly stopped proliferating when infected with a retrovirus encoding p19
ARF
. Both early (Harvey et al., 1993) . In principle, p19 ARF might exert its with rabbit antiserum to CDK4 (bottom).
effects through a p53-regulated gene such as p21 Cip1 (ElDeiry et al., 1993) , which was cloned as a senescent cellderived growth inhibitor (Noda et al., 1994) . In agreement derived cell lines containing mutant p53. We have only with this hypothesis, basal p21 Cip1 levels were reduced negative evidence that p53 directly regulates p19 ARF exin ARF Ϫ/Ϫ versus ARF ϩ/ϩ MEFs, and enforced exprespression in fibroblasts (Quelle et al., 1997) ing growth arrest, loss of both proteins can occur in mutations, whereas those that deleted ARF preserved tumor cells. We found that a fibrosarcoma that arose p53 function. Lines with mutant p53 rapidly become spontaneously in an ARF Ϫ/Ϫ mouse had lost p53 but polyploid (Levine, 1997) , whereas ARF-null lines that retained wild-type p16
INK4a
, indicating that p19 ARF and retain p53 function seem to remain pseudodiploid p53 can likely collaborate in tumor progression. One through more passages. In mice then, p53 and ARF obvious possibility is that p53 can regulate apoptotic inactivation appear to represent alternative mechanisms functions in ARF Ϫ/Ϫ cells unrelated to cell cycle progresfor bypassing the senescence block, and p53 loss predisposes more strongly to changes in ploidy (Fukusawa sion per se.
color were mated to C57Bl/6 females. which predominated in their studies (as in p53-null mice glutamine, and 100 U/ml penicillin and streptomycin (GIBCO, Grand [Donehower et al., 1992; Jacks et al., 1994; Kemp et al., Island, NY) . Balb-3T3 (10)1 and (10) translated. Ultimately, then, the extent to which p16
INK4a solution containing 0.53 mM EDTA) for 10 min at 37ЊC, using 1 ml loss independently contributes to tumorigenesis in mice per embryo. Trypsin was inactivated by addition of DMEM conwill require analysis of a p16Ϫnull/ARF-positive strain.
taining 10% FBS and 2 mM glutamine, 0.1 mM MEM nonessential amino acids, 55 M 2-mercaptoethanol, and 10 g/ml gentamycin.
Data implicating p16
INK4a as a tumor suppressor in Cells from single embryos were plated into two 60 mm diameter humans remains compelling. In certain tumor types, inculture dishes and incubated at 37ЊC in a 10% CO2 humidified chamactivating point mutations of p16 INK4a are common, ber. Cells were maintained on a defined schedule (9 ϫ 10 5 cells whereas deletions are rare (Hirama and Koeffler, 1995;  per 60 mm diameter dish passaged every 3 days). Plating after Hall and Peters, 1996; Pollock et al., 1996) . Some muta- affect both reading frames can selectively target p16
INK4a (Quelle et al., 1997 (Van Deursen et al., 1995) using p19 ARFfor 2 days. One plate was used for detection of ␤-galactosidasespecific cDNA probes (Quelle et al., 1995b) . Restriction enzyme positive cells in order to estimate transfection efficiency. Cells from maps of the INK4a and INK4b loci were determined using bacterial the other plate were distributed equally into three 60 mm diameter artificial chromosome (BAC) clones (Genome Systems, St. Louis, culture dishes, grown in complete medium containing 5% FBS, and MO). To construct the targeting vector, a 1 kb SmaI fragment conrefed with fresh medium every 2 days. Twenty-one days posttaining Exon 1␤ was deleted and replaced with a neo cassette transfection, cells were fixed and stained with Giemsa. Unfixed foci flanked by 2.5 kb EcoRI (E) to SmaI (Sm) and 5 kb SmaI to SpeI (S) of morphologically transformed cells were subcloned using microfragments derived from the ARF locus; screening of ES cell clones cylinders, expanded, and tested for anchorage-independent growth was performed by digestion of genomic DNA with AflII ( Figure 1A) . in 0.3% Noble agar (2 ϫ 10 4 cells per dish) in Iscove's medium supplemented with 15% FBS, and colonies were scored 2-3 weeks later. (Quelle et al., 1995b) . Cell supernatants containing infectious ␤-D-arabinofuranosyl]-5-iodouracil (FIAU; Bristol-Myers Squibb, Princeton, NJ) (Van Deursen et al., 1995) . Three hundred ES colonies retroviral pseudotypes were harvested 24-60 hr posttransfection, pooled on ice, and filtered (0.45 mm membrane). Infections of expodoubly resistant to G418 and FIAU were analyzed for homologous recombination using AflII and a 1.0 kb SpeI-ClaI probe ( Figure 1A) . nentially growing mouse fibroblasts were performed in an 8% CO 2 atmosphere with 2 ml of virus-containing culture supernatant conFour ES clones heterozygous for exon 1␤ were injected into C57Bl/6 blastocysts, which were subsequently implanted into the uteri of taining 10 mg/ml polybrene (Sigma, St. Louis, MO) for each 100 mm diameter plate culture. After 3 hr, 10 ml fresh medium was added. References removed by centrifugation in a microfuge at 12,000 RPM for 10 min at 4ЊC. Proteins (1 mg/ml) were immunoprecipitated, electrophoretiAlcorta, D.A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and cally separated on denaturing polyacrylamide gels containing sodium Barrett, J.C. (1996) . Involvement of the cyclin-dependent kinase dodecyl sulfate (SDS), transferred to nitrocellulose, and detected inhibitor p16 (INK4a) in replicative senescence of normal human using affinity-purified rabbit antibodies raised to the C-termifibroblasts. Proc. Natl. Acad. Sci. USA 93, 13742-13747. nal peptides of either p16
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INK4a or p19 ARF (Quelle et al., 1995a (Quelle et al., , 1995b . Sites of antibody binding were visualized by enhanced chemilumiDeng, C., Zhang, P., Harper, J.W., Elledge, S.J., and Leder, P. (1995) . nescence (ECL, Amersham). Where indicated, p16
INK4a immunopreMice lacking p21 CIP1/WAF1 undergo normal development, but are decipitates were separated on gels and blotted with rabbit antiserum fective in G1 checkpoint control. Cell 82, [675] [676] [677] [678] [679] [680] [681] [682] [683] [684] Cip1 and p53 were visualized by direct immunoblotting Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montwith commercial antibodies (monoclonal F-5 [Santa Cruz Biochemigomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992 NaCl, 5 mM (1995) . A new type of p16 INK4/MTS1 gene transcript expressed in B-cell EDTA, and 0.5% Nonidet P-40. Centrifuged cell lysates were precipimalignancies. Oncogene 11, 21-29. tated using PAb246, a mouse-specific and conformation-dependent El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., antibody that recognizes wild-type but generally not mutant p53 Trent, J.M., Lin, D., Mercer, E., Kinzler, K.W., and Vogelstein, B. (Yewdell et al., 1986) , and PAb240, a panspecific antibody that rec-(1993). WAF1, a potential mediator of p53 tumor suppression. Cell ognizes many mutant p53s but not the wild-type protein in its native 75, 817-825. conformation (Gannon et al., 1990) . Precipitates were solubilized Fitzgerald, M.G., Harkin, D.P., Silva-Arrieta, S., MacDonald, D.J., in gel sample buffer, electrophoretically separated on denaturing Lucchina, L.C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D.M., Isselpolyacrylamide gels, and visualized by autoradiography of the dried bacher, K.J. , et al. (1996) . Prevalence of germ-line mutations in p16, slab gels. p19 ARF , and CDK4 in familial melanoma: analysis of a clinic-based population. Proc. Natl. Acad. Sci. USA 93, 8541-8545.
Radiation Response
Fukusawa, K., Choi, T., Kuriyama, R., Rulong, S., and Vande Woude, Replicative DNA synthesis was quantitated by bivariate flow cytom-G.F. (1996) Abnormal centrosome amplification in the absence of etry following procedures for irradiation described by others (Deng p53. Science 271, 1744 -1747 . In brief, cells made quiescent by serum starvation for Gannon, J.V., Greaves, R., Iggo, R., and Lane, D.P. (1990) . Activating 96 hr were irradiated with 5 or 20 Gy and then released into complete mutations in p53 produce a common conformational effect: a monomedium containing 10% FBS and 65 M BrdU. Cells were fixed 24 clonal antibody specific for the mutant form. EMBO J. 9, 1595-1602. hr later in 70% ethanol and kept at Ϫ20ЊC until analysis. We comGottlieb, T.M., and Oren, M. (1996) . p53 in growth control and neopared two independently derived ARF ϩ/ϩ strains (2 cultures of each) plasia. Biochim. Biophys. Acta 1287, 77-102. with two ARF Ϫ/Ϫ strains (2 cultures) in two separate experiments. Data for ϩ/ϩ and Ϫ/Ϫ strains in each experiment were separately Gruis, N.A., van der Velden, P.A., Sandkuijl, L.A., Prins, D.E., Weaverpooled. Fixed cells were incubated in 4N HCl for 30 min at room Feldhaus, J., Kamb, A., Bergman, W., and Frants, R. (1995). Homozytemperature, washed with PBS, and resuspended in 0.1 M Borax gotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nature Genet. 10, 351-353. containing 0.1% Tween-30 and 0.1% BSA. Cells were exposed for
